#therapeutics — Tuesday, July 14, 2026 (4 items)
| 0 | ℹ |
In silico design and validation of high-affinity RNA aptamers for SARS-CoV-2 comparable to neutralizing antibodies.
(elifesciences.org)
|
eLife 2026-07-14 | #covid-19 #aptamers #protein-binding #molecular docking #therapeutics | |
| 0 | ℹ |
Targeted alpha-synuclein mRNA degradation by PMO-based RNA-degrading chimeras.
(pnas.org)
|
PNAS 2026-07-14 | #neurodegeneration #antisense #synucleinopathy #therapeutics #antisense rna | |
| 0 | ℹ |
Oncogenic snoRNA SNORD78 fuels colorectal cancer by protecting the m(6)A reader IMP2 to enhance phospholipid metabolism.
(pnas.org)
|
PNAS 2026-07-14 | #colorectal cancer #metabolism #methylation #therapeutics | |
| 0 | ℹ |
The global preclinical research and development landscape for pre-eclampsia and eclampsia therapies.
(nature.com)
|
Communications Medicine 2026-07-14 | #pre-eclampsia #drug development #preclinical #therapeutics #pregnancy |